Literature DB >> 3300818

Immunohistochemical evaluation of bone marrow involvement in hairy cell leukemia during interferon therapy.

D Soligo, G Lambertenghi-Deliliers, E Berti, N Polli, E E Polli.   

Abstract

Bone marrow biopsies from 7 patients afflicted with hairy cell leukemia were studied with a panel of monoclonal antibodies at different intervals during alpha recombinant interferon therapy. Monoclonal antibodies Dako-LC and F 8.11.13 were used because they are highly reactive with hairy cells, and 82H3 and LeuM 1 were also utilized to identify respectively the residual hemopoietic and myeloid tissue. All antibodies are reactive on sections of formalin-fixed, paraffin-embedded biopsy material. Before therapy a uniform hairy cell infiltrate was present and very little tissue was visible even after immunohistochemical staining. During therapy, identification of hairy cells in routine biopsies was difficult, since they were mixed with normal cells and the bone marrow was generally hypoplastic. Immunohistochemical stains seem to allow better identification of hairy cells and a more precise estimate of the degree of repopulation by normal bone marrow cells. It was evident, especially after immunocytochemical analysis, that interferon drastically reduced the extent of the infiltrate and allowed recovery of normal hemopoiesis, but did not produce complete remissions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300818     DOI: 10.1007/BF00631783

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  12 in total

1.  Scanning immunoelectron microscopy of hairy cell leukemia.

Authors:  D Soligo; G Lambertenghi-Deliliers; M T Nava; N Polli; G Cattoretti; E E Polli
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.

Authors:  S N Hanjan; J F Kearney; M D Cooper
Journal:  Clin Immunol Immunopathol       Date:  1982-05

4.  Phenotype study of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy.

Authors:  M Divine; J P Farcet; M F Gourdin; A Tabilio; A Vasconcelos; C Andre; H Jouault; J Bouguet; F Reyes
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

5.  Alpha interferon for induction of remission in hairy-cell leukemia.

Authors:  J R Quesada; J Reuben; J T Manning; E M Hersh; J U Gutterman
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

6.  Monoclonal antibodies with specificity for hairy cell leukemia cells.

Authors:  D N Posnett; N Chiorazzi; H G Kunkel
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Leukocyte common antigen--a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization.

Authors:  P J Kurtin; G S Pinkus
Journal:  Hum Pathol       Date:  1985-04       Impact factor: 3.466

8.  Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

9.  Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia.

Authors:  H M Golomb; E H Kraut; D L Oviatt; E J Prendergast; R S Stein; D L Sweet
Journal:  Am J Hematol       Date:  1983-02       Impact factor: 10.047

10.  Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.

Authors:  R A Warnke; K C Gatter; B Falini; P Hildreth; R E Woolston; K Pulford; J L Cordell; B Cohen; C De Wolf-Peeters; D Y Mason
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.